Mental Health DailyResearch. Evidence. Perspective.Published research on cognitive deficits.
Transcranial Direct Current Stimulation (tDCS) has been explored as a potential treatment for major depressive disorder (MDD), particularly for patients who have not responded to traditional…
Read articleElectroconvulsive therapy (ECT) has long been a controversial yet potent treatment for major depressive disorder (MDD), particularly in cases resistant to conventional therapies. Despite its…
Read articleDepression, a prevalent mental health issue, often resists traditional treatments, making innovative approaches necessary. Recent research suggests that ‘aesthetic chills’—a peak emotional r…
Read articleObesity now affects over 650 million adults globally and is a major risk factor for various chronic diseases including cognitive decline and impairment. Recent evidence shows a link between …
Read articleA large prospective study has uncovered two blood biomarker profiles measured during acute COVID-19 that are associated with cognitive deficits months later. Higher fibrinogen and lower C-re…
Read articleQsymia is a weight loss drug engineered by the California-based pharmaceutical company Vivus Inc. It was initially approved by the FDA in 2012 for weight reduction among adults with BMIs (bo…
Read article
